Schedule 13G ownership disclosure

SCYNEXIS INC COM NEW

Security class unavailable · CUSIP: 811292101

Event date: 2019-12-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
55,555,561
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-075584
Form type
SC 13G
Filer
Decheng Capital China Life Sciences USD Fund III, L.P.
CIK
CIK 1736814
Filed
Dec 23, 2019
Reporting period
Dec 12, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub